![Image](data:image/png;base64,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)

## Acta Chirurgica Belgica

ISSN: 0001-5458 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/tacb20

## The Influence of Intraoperative Factors and Histopathological Staging on the Performance of Sentinel Node Biopsy in Colon Cancer

## D. Murawa, P. Nowaczyk, A. Spychata, M. Hunerbein & M. Michat

To cite this article: D. Murawa, P. Nowaczyk, A. Spychata, M. Hunerbein & M. Michat (2015) The Influence of Intraoperative Factors and Histopathological Staging on the Performance of Sentinel Node Biopsy in Colon Cancer, Acta Chirurgica Belgica, 115:3, 184-190, DOI: 10.1080/00015458.2015.11681094

To link to this article: http://dx.doi.org/10.1080/00015458.2015.11681094

![Image](data:image/png;base64,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)

![Image](data:image/png;base64,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)

![Image](data:image/png;base64,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)

![Image](data:image/png;base64,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)

![Image](data:image/png;base64,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)

Published online: 11 Mar 2016.

Submit your article to this journal

Article views: 2

View related articles

View Crossmark data

Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=tacb20

![Image](data:image/png;base64,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)

## Original papers

Acta Chir Belg , 2015, 115 , 184-190

## The Influence of Intraoperative Factors and Histopathological Staging on the Performance of Sentinel Node Biopsy in Colon Cancer

D. Murawa 1 , P. Nowaczyk 1 , A. Spychała 1 , M. Hünerbein 2 , M. Michał 3

1 First Clinic of Surgical Oncology and General Surgery, Wielkopolska Cancer Centre, Poznań, Poland ; 2 Department of General Surgery and Surgical Oncology, Robert-Rössle-Klinik, Helios Hospital Berlin-Buch, CCB, Berlin, Germany ; 3 Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznań, Poland.

Abstract. Background : The aim of this study was to assess sentinel node biopsy (SNB) results in colon cancer (CC) regarding intraoperative staging of the disease and pathological cancer features.

Results : ROC  curve  analysis  did  not  reveal  any  statistical  significance  for  tumour  measurements  (all  p > 0.05). Statistically significantly worse results in sensitivity (not in accuracy) were achieved for T3 tumours in comparison with T2 tumours (83% vs 89%, p = 0.0066). Statistically significantly worse results in accuracy (not in sensitivity) of the method were obtained in the cases of involved lymph nodes (78% vs 100%, p < 0.0001), infiltration of the lymph node capsule (80% vs 97%, p = 0.0023) and infiltration of the perinodal tissue (73% vs 97%, p = 0.0002). The analyses of SNB sensitivity and accuracy in combination with other features showed no statistical significance (all p > 0.05). Conclusions : The sensitivity of the method is significantly worse for tumours with deeper infiltration of intestinal wall. The presence of nodal metastases, lymph node capsule and perinodal invasion significantly affects the accuracy results of SNB in CC. The problem of qualifying patients for the procedure in regard to the other analysed features, however, remains open and requires further analysis.

Material and Methods : The study was conducted on the basis of 132 SNBs in CC. The elements of intraoperative staging of the disease and pathological cancer features were compared with accur  acy, sensitivity and false negative results of SNB in CC by means of ROC curves and the tests for population proportions.

## Abbreviations

CC, colon cancer ; CRC, colorectal cancer ; LM, lymphatic mapping ; SN, sentinel node ; SNB, sentinel node biopsy

## Introduction

Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of death due to cancer in the whole world (respectively over 1.23 million cases and over 609 thousand deceased in 2008 (1). At the same time, owing to the constant improvement of diagnostics and screening programmes, it has progressively been diagnosed in earlier stages. The presence of metastases in lymph nodes is the most significant prognostic factor. The  diagnosis  of  lymphatic  metastases  decreases  the 5-year survival rate from ca 75-90% to 40-60%, and it  also  determines  recommendation  for  chemotherapy in colon cancer (CC) (2-11). A group of patients with disease stage I and II, in which even as many as 30% of the patients may have remote metastases during the next 5 years and die due to CRC, remains a problem (4, 7-13). The cause of such incidents is most commonly the primary undervaluation of cancer advancement, and thus

omitting micrometastases or isolated cancer cells during standard histopathological examination, which are likely to be found in almost 50% of patients with stage I and II of the disease (3-11, 14).  At present, the improvement in the capabilities of lymph node diagnostics seems to be the most important in further treatment (3, 8, 10, 13). Therefore, the possibility of sentinel node biopsy (SNB) in CC, and the collection for more detailed analyses of the first nodal group on the route of lymph flow from a tumour, seems to be a solution (4-13, 15, 16). The term of upstaging is applicable here - it concerns a group of patients with positive nodes found with another method than standard histopathological staining. Such a group, despite the ongoing discussion on the role and importance of micrometastases and isolated cancer cells, is also a potential beneficiary of adjuvant chemotherapy (17, 18). However, en-bloc resection of the tumour with a margin of healthy tissue and the mesentheric lymphatic system remains a standard surgical treatment (19-21).

At present the procedure, despite not entirely satisfactory  results,  mainly  in  sensitivity,  is  increasingly recommended as an examination providing prognostically significant information (16, 17).  Furthermore, there is a problem concerning the selection of the group of patients

who  could  be  the  greatest  beneficiaries  of  lymphatic mapping (LM). On the one hand, the qualification should take  into  account  anthropometric  factors  of  a  patient which may influence the easiness and quality of LM (22, 23), and, on the other, the clinical intraoperative picture of neoplastic disease seems to be very important.

In view of that, the aim of the present study was to  evaluate  the  results  of  SNB  in  CC  depending  on basic features of the disease, assessed both clinically, intraoperatively macroscopically, and in the final microscopic examination.

## Material and Methods

Since May 2005 until December 2012, 132 SNB in CC were  carried  out  in  the  First  Department  of  Surgical Oncology  and  General  Sugery,  Wielkopolska  Cancer Centre in Poznań. The study group included 65 women and 67 men. The average age of the patients was 62.75 (median 64, IQR 56-70). The division of the patients depending on cancer stage was carried out according to the AJCC Cancer Staging Manual, Seventh Edition 2010 (Table 1).

The inclusion criteria were as follows : age > 18 years, consent to the examination, ASA I-III, histopathologically confirmed and initially resectable colon cancer, lack of earlier surgical intervention on the colon and its mesentery, information on lack of allergy to contrast agents. The  procedure  was  abandoned  in  pregnant  women, patients with intraoperatively suspected lymph nodes, T4 tumours, remote metastases, synchronous tumours and in procedures due to emergency indications (obstruction). Each patient after laparotomy and gentle mobilisation of a segment of the large intestine intended for resection received  2-4  ml  of  Patent  Blue  dye  in  4  subserosal injections near the tumour. The node dyed as the first one after 5-10 min. was determined as a sentinel node (SN).

The  procedure  itself  consisted  of  the  classic  en-bloc resection of the tumour with a margin of healthy tissue and the mesenteric lymphatic system. The cases with no macrometastases  in  SNs,  apart  from  standard  H + E staining, underwent immunohistochemical staining with anti-cytokeratin  antibodies  -  CKAE1/AE3,  CAM  5,2, CKMNF116.  Nodes  with  macrometastases  in  H + E staining and nodes with immunohistochemically diagnosed micrometastases - foci of neoplastic cells of the size of 0.2-2 mm, were considered positive SNs.

The results for tumour measurements were analysed by means of ROC graphs. The other results obtained were analysed in terms of method sensitivity and accuracy, each time two groups were compared with the use of the test for population proportions.

Detection,  sensitivity  and  accuracy  of  the  method were calculated for the assessment of SNB procedure. Also  upstaging,  false  negative  results  and  negative predictive values were calculated. Then results of SNB were  analysed  depending  on  macroscopic,  clinically diagnosed features and microscopic picture of cancer. Based  on  previous  reports,  we  analysed  only  those features, which could change or alter lymphatic drainage. The analysed elements are shown in Table 2.

The study has been approved by the Bioethical Committee of the Poznan University of Medical Sciences.

## Results

On average, 14.2 lymph nodes (median 14, IQR 9.2518) were analysed in a preparation. In 63.4% (84/132) of patients, 12 or more nodes were analysed. The median number of SNs analysed was 3 (IQR 2-4). The results of the procedure are shown in Table 3. In the case of patients with aberrant lymphatic drainage after tracer administration the nodes in the area of the root of the mesentery were the first to be stained.

Table 1. Division of material in terms of cancer staging according to the TNM, Classification of Malignant Tumours by Dukes and Dukes, modified by Astler and Coller (in accordance with AJCC Cancer Staging Manual, Seventh Edition 2010).

| Stage   | T   | N   | M   | Dukes   | MAC   | Patients (%)   |
|---------|-----|-----|-----|---------|-------|----------------|
| 0       | Tis | N0  | M0  | -       | -     | 5 (3.8%)       |
| I       | T1  | N0  | M0  | A       | A     | 8 (6.0%)       |
| I       | T2  | N0  | M0  | A       | B1    | 21 (15.9%)     |
| IIA     | T3  | N0  | M0  | B       | B2    | 62 (47.0%)     |
| IIIA    | T2  | N1a | M0  | C       | C1    | 2 (1.5%)       |
| IIIA    | T2  | N1b | M0  | C       | C1    | 1 (0.8%)       |
| IIIB    | T2  | N2a | M0  | C       | C1    | 2 (1.5%)       |
| IIIB    | T2  | N2b | M0  | C       | C1    | 1 (0.8%)       |
| IIIB    | T3  | N1a | M0  | C       | C2    | 12 (9.1%)      |
| IIIB    | T3  | N1b | M0  | C       | C2    | 8 (6.0%)       |
| IIIB    | T3  | N2a | M0  | C       | C2    | 6 (4.5%)       |
| IIIC    | T3  | N2b | M0  | C       | C2    | 3 (2.3%)       |
| IIIC    | T4a | N2a | M0  | C       | C2    | 1 (0.8%)       |

Table 2. Intraoperative, macroscopic and pathological factors influencing the sentinel node biopsy results.Table 3. The global results of sentinel lymph node biopsy in colon cancer in the presented material.

| Intraoperative and macroscopic features                                                                                                                                             | Intraoperative and macroscopic features   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|
| 1.  Intraoperative location of the disease in the colon : -  Right vs left half of the colon -  Sigmoid colon vs other locations                                                    |                                           |
| 2.  Cancer macroscopic features :                                                                                                                                                   |                                           |
| -  Presence of ulceration vs lack of ulceration                                                                                                                                     |                                           |
| -  Maximum tumour size in cm (the maximum length measured on the specimen)                                                                                                          |                                           |
| -  Tumour surface area in cm 2  determined at a rough estimate with the use of the formula for ellipse surface area (tumour surface area =    π × ½ tumour length × ½ tumour width) |                                           |
| -  Percentage of involvement of circular lumen of the intestine                                                                                                                     |                                           |
| Pathological features                                                                                                                                                               | Pathological features                     |
| 1.  Tumour grade (G1-G3)                                                                                                                                                            |                                           |
| 2. T stage                                                                                                                                                                          |                                           |
| 3. TNM tumour stage                                                                                                                                                                 |                                           |
| 4.  Presence of macrometastases                                                                                                                                                     |                                           |
| 5.  Infiltration of the lymph node capsule, infiltration of perinodal tissue                                                                                                        |                                           |
| 6. Vascular invasion                                                                                                                                                                |                                           |
| 7.  Presence of desmoplastic and inflammatory response in tumour                                                                                                                    |                                           |

| Measure                                                                                                        | Value in %      |
|----------------------------------------------------------------------------------------------------------------|-----------------|
| Detection rate                                                                                                 | 99.2% (131/132) |
| Accuracy                                                                                                       | 94.7% (124/131) |
| Sensitivity                                                                                                    | 84.4% (38/45)   |
| False negative rate                                                                                            | 15.6% (7/45)    |
| Negative predictive value                                                                                      | 92.5% (86/93)   |
| Upstaging                                                                                                      | 9.5% (9/95)     |
| Sentinel  node  as  the  only  site  of  metastases  within  lymph  nodes  after  immunohistochemical staining | 37.8% (17/45)   |
| Aberrant lymphatic drainage                                                                                    | 3.1% (4/131)    |

No  statistically  significant  differences  in  sensitivity and accuracy of the method were found in the examination of  results  of  the  procedure  depending  on  features observed intraoperatively and macroscopically. The ROC curve analysis did not demonstrate statistically significant relationships  for  maximum tumour size (AUC = 0.565, p = 0.1219),  tumour  surface  area  (AUC = 0.569,  p = 0.1077) and for percentage of involvement of circular lumen of the intestine (AUC = 0.550, p = 0.1700). Other results of the analysis of macroscopic features (test for popu   lation proportions) are presented in Table 4.

The analysis of tumour grade (G1-G3) did not show any statistically significant differences in sensitivity and ac curacy  of  the  method.  Statistically  significant  differences were demonstrated in the analysis of sensitivity results depending on depth of intestinal wall infiltration -  the  worst  results  were  obtained  for  T3  tumours compared  with  T2  (83%  vs  89%,  p = 0.0066).  This difference was not demonstrated in the accuracy analysis depending on T stage. Taking into account the presence of metastases in the regional lymph nodes, statistically significantly  worse  results  in  accuracy  of  the  method were obtained in the cases of involved lymph nodes (78%

vs  100%,  p < 0.0001).  Statistical  significance  was  not demonstrated in the sensitivity analysis depending on the status of the lymphatic system. Similarly, no influence of the degree of lymphatic system involvement (N1 vs N2) on the obtained results of the procedure was demonstrated both in terms of sensitivity and accuracy. However, the investigation indicated that the presence of infiltration of the lymph node capsule in the whole nodal material (80% vs 97%, p = 0.0023) and the infiltration of the perinodal tissue  (73%  vs  97%,  p = 0.0002)  significantly  affects accuracy of the procedure without influencing its sen sitivity. Similar relationships were obtained in the analysis of  the  above  features  for  non-sentinel  lymph  nodes, where  both  in  the  case  of  diagnosis  of  infiltration  of the  lymph  node  capsule  (80%  vs  97%,  p = 0.0023) and  infiltration  of  the  perinodal  tissue  (71%  vs  97%, p = 0.0001), results concerning accuracy were statistically significantly  worse.  Similarly,  as  in  the  analysis  of  the whole  nodal  material,  these  relationships  were  not confirmed in the analysis of procedure sensitivity for the above features in non-sentinel lymph nodes. The identification of vascular invasion had no influence on sensitivity and accuracy of the method, and, paradoxically,

Table 4 . Results of sensitivity and accuracy analysis of sentinel node biopsy depending on tumour localisation and its macroscopic features.

| Sensitivity                                  | Sensitivity   | Sensitivity   | Sensitivity   | Sensitivity   |
|----------------------------------------------|---------------|---------------|---------------|---------------|
| Right vs half of the colon                   | 85%           | vs            | 84%           | p = 0.9269    |
| Sigmoid colon vs other locations             | 88%           | vs            | 81%           | p = 0.5148    |
| Presence of ulceration vs lack of ulceration | 81%           | vs            | 89%           | p =  0.4710   |
| Accuracy                                     | Accuracy      | Accuracy      | Accuracy      | Accuracy      |
| Right vs half of the colon                   | 94%           | vs            | 95%           | p = 0.8054    |
| Sigmoid colon vs other locations             | 96%           | vs            | 94%           | p = 0.5984    |
| Presence of ulceration vs lack of ulceration | 93%           | vs            | 97%           | p = 0.2991    |

the outcomes were statistically not meaningfully better in the group of patients with identified cancer cells within vessels. Comparison of accuracy and TNM tumour stage did not reveal any relationships for stages 0 vs I vs II vs III. Distinction between individual groups in TNM stages gave  statistically  significant  differences  in  accuracy  in the  following  analyses :  I  vs  III  (100%  vs  81%, p = 0.0131), II vs III (100% vs 81%, p = 0,0004). No statistically  relevant relationships were obtained in the sensitivity analysis of the method in relation to TNM tumour stage. Likewise, no connection was found between the obtained results and the presence of desmoplastic and inflammatory response within the tumour.

## Discussion

The commonly adopted criteria for the qualification of patients for SNB, correspondingly applied in our study group, are presented in the Material and Methods section. One  important  criterion  was  the  adequate  selection  of patients in terms of the location of cancer disease in the large intestine. Many of the analysed publications present the percentage of rectal cancer patients (from 9 to as much as 74% in the study group). LM in the rectum compared to the colon is much more arduous and  definitely  less  reliable,  causing  many  technical difficulties (9,  16,  20,  21,  23).  It  is  worth  emphasizing that in the light of the current standards, patients with rectal cancer preoperatively undergo neoadjuvant therapy in  most  European  and  Northern  American  countries, which results in reactive changes in mesorectal lymphatic  vessels  and  tissues.  Another  major  problem  is the necessity of leaving intact mesorectal fascia during rectal resection - the total resection of the mesorectum is a condition of successful oncological treatment of these patients. Consequently, patients with rectal cancer were excluded from the present analysis.

Few researchers indicate that tumours located in the sigmoid  colon  have  statistically  significantly  higher detection rate than those located in the right or left part of the colon. Such a state may result from better mobility of this part of the large intestine, which enables better exposure without the need to perform quite an extensive

mobilisation which causes damage to lymphatic vessels in the mesentery (24). The above relationships were not confirmed in our analysis.

The  data  found  in  the  literature  on  the  influence  of lymphatic and blood vessel invasion on the results of SNB in CC is rather scarce. The existing reports suggest that detection of lymphatic vessel invasion considerably affects sensitivity of SNB. Suggestions concerning blood vessel invasion are similar, yet supported by less data. Yet another important issue that is indisputably linked with disrupted lymphatic drainage from tumour is the presence of skip metastases, i.e. metastases in lymph nodes when omitting  their  first  anatomical  station.  This  problem concerns even T2 tumours with massive involvement of lymphatic vessels (20, 27). A study by W ASIF et al . on the impact of individual factors on the result of upstaging obtained  in  the  whole  nodal  material  of  N0  patients demonstrated  that  lymphatic  vessel  involvement  is  a factor that substantially increases the risk of detection of micrometastases (16% vs 3%, p < 0.001) (28). A similar relationship  between  vessel  invasion  and  presence  of isolated cancer cells was found in a retrospective study by

Yet another basic criterion for qualification of patients for SNB in CC is lack of clinical features of lymph node involvement  (lack  of  nodal  deposits  and  infiltration  in continuity)  and  lack  of  remote  metastases.  However, in  some  studies  the  only  inclusion  criterion  was  the presence of resectable cancer. LM in the situation of the identification  of  features  of  massive  node  involvement (together  with  total  lymph  node  destruction)  results, above  all,  in  the  problem  of  lack  of  SN  identification. Another  additional  problem,  resulting  from  blockage of lymphatic vessels and of nodes only with tumour deposits, may be the collection of wrong nodal stations for the analysis (not sentinel lymph nodes by definition), the outcome of which is a considerable increase in the false negative rate - when accidentally stained nodal stations  are  subjected  to  the  analysis (25,  26).  In  the present material, patients with macroscopic nodal disease were  disqualified  from  SNB,  and,  additionally,  we demonstrated statistically worse accuracy of the method in the presence of macrometastases in the nodal material and non-SNs.

| Conclusions lack of determination of relationships between tumour size and  results of SNB   | lack  of  a  statistically  significant  dif ference  in  percentage  of  FNR  for  tumours < 4  cm  and ≥ 4 cm (60% vs 50%, p = 0.6)   | lack of determination of relationships between tumour size and  results of SNB   | the  study  group  had  statistically  significantly  smaller  mean  tumour  size  in  comparison  control  group  (3.6  vs  4.8  cm,  p <  0.001),  yet  significantly  higher  percentage  of   | < 0.01)   | with  the  metastases in nodes was found in the study group (53% vs 36%, p significant  dif ference  between  DR  and  dye  amount  diameter  (mean  0.55  ml/cm  in  the  case  for  TP   | a  in  ml  given  per  1  cm  of  maximum  tumour  of  identification  and  0.31  ml/cm  in  the  case of no identification, p = 0.04) upward  trend  of  FNR  percentage  togethe r  with   | an  increase  in  tumour  size  (mean  3.4  cm   and 4.5 cm for FN, p  = 0.09) lack of statistical significance between tumour size and DR   | lack of determination of relationships between tumour size and  results of SNB significant  decrease   | a  statistically  in  DR  together  with  an  increase  in  tumour  size  (p = 0.036), without determination of the cut-of f point   | lack of determination of relationships between tumour size and  results of SNB   |
|----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|
| FNR  (%)                                                                                     | 0 50                                                                                                                                    | 9                                                                                | 8                                                                                                                                                                                                 |           | 50                                                                                                                                                                                         |                                                                                                                                                                                              |                                                                                                                                              | 12                                                                                                     | 33                                                                                                                                   | 4                                                                                |
| Sensitivity (%)                                                                              | 100 50                                                                                                                                  | 91                                                                               | 92                                                                                                                                                                                                |           | 50                                                                                                                                                                                         |                                                                                                                                                                                              |                                                                                                                                              | 88                                                                                                     | 67                                                                                                                                   | 55                                                                               |
| Ratio T12:T34 (%)                                                                            | 91:9 34:66                                                                                                                              | 80:20 100 96                                                                     | 42:58                                                                                                                                                                                             |           | 16:84                                                                                                                                                                                      |                                                                                                                                                                                              |                                                                                                                                              | 32:68                                                                                                  | 14:86                                                                                                                                | 22:78                                                                            |
| Mean size,  range (cm)                                                                       | 2.4, 0.2-8.0                                                                                                                            | 2.3, 0.5-5                                                                       |                                                                                                                                                                                                   |           | 4.2 * , 2-7.2                                                                                                                                                                              |                                                                                                                                                                                              | 2006                                                                                                                                         | 2006                                                                                                   | 2006                                                                                                                                 | 4.1, 1.5-16.0                                                                    |
| No. of patients                                                                              | 11 40 -, -                                                                                                                              | 2003 30                                                                          | 102 3.6, -                                                                                                                                                                                        |           | 31                                                                                                                                                                                         |                                                                                                                                                                                              |                                                                                                                                              | 97 3.58, 0.2-10.5 22 8.3, 2-32.5                                                                       |                                                                                                                                      | 174                                                                              |
| Y ear                                                                                        | 2001 ILLA  (10) 2002                                                                                                                    |                                                                                  | 2003                                                                                                                                                                                              |           |                                                                                                                                                                                            | 2003                                                                                                                                                                                         |                                                                                                                                              | 2008                                                                                                   | (13)                                                                                                                                 | 2013                                                                             |
| Author                                                                                       |                                                                                                                                         |                                                                                  |                                                                                                                                                                                                   |           | (28)                                                                                                                                                                                       |                                                                                                                                                                                              |                                                                                                                                              | UADROS                                                                                                 | (23)                                                                                                                                 | (23)                                                                             |
| Author                                                                                       | RODERICK -V                                                                                                                             | ILCHIK  (12)                                                                     | (5)                                                                                                                                                                                               |           | (1 1)                                                                                                                                                                                      |                                                                                                                                                                                              |                                                                                                                                              |                                                                                                        |                                                                                                                                      |                                                                                  |
|                                                                                              | W OOD  (29) B                                                                                                                           | B                                                                                | B ILCHIK                                                                                                                                                                                          |           | V IEHL                                                                                                                                                                                     |                                                                                                                                                                                              |                                                                                                                                              | B ILCHIK                                                                                               | Q                                                                                                                                    | V IEHL                                                                           |

T able 5. Absolute tumour size in centimeters and its influence on the par ameters obtained in sentinel node biopsy in colon cancer .

M ESCOLI et al . (14). In the present study no influence of vessel invasion on sensitivity and accuracy of the method was found ; however, we demonstrated that infiltration of the lymph node capsule and perinodal tissue statistically significantly  affected  the  accuracy. The  situation  might change if we analyse the extension of vessel invasion, but we did not have any information defining this feature. The work of W ASIF et al . showed manifestly greater prevalence of isolated cancer cells in the group of patients with  poorly  differentiated  (G3)  cancer  (28%  vs  12%, p = 0.022) (28). However, our study did not confirm this fact.

What  is  more,  few  studies  covered  a  relationship between SNB parameters and absolute tumour size, and some of them established that a higher number of false negative  results  was  found  for  patients  with  greater absolute tumour size in centimetres. Detection rate and sensitivity in the case of T1 and T2 stage lesions are statistically  significantly  better  for  smaller  tumours (diameter < 35 mm) (4, 6, 9, 13). In single reports, the

One  of  the  most  frequent  problems  concerning  the analysis of material from SNB in CC is the presence of a great number of T3 and T4 tumours, accounting for as much as 70% of the study group (7, 8, 13, 24). This fact is related to decreased detection, higher false negative rate and an increased number of skip metastases - tumour penetration  through  the  wall  may  cause  compression of  lymphatic  vessels  and  change  the  original  lymph drainage from the tumour. The above discussion seems to be confirmed by studies on groups of patients with less advanced cancer (T1 and T2), where detection rate and accuracy amount to nearly 100% (8, 20). However, it is not confirmed by the latest research by V IEHL et al . and meta-analysis by van der P AS et al ., where statistically significant differences in SNB sensitivity depending on T stage of the tumour were not found (17, 23). Additionally, it was demonstrated in the above-cited study by W ASIF et al . that isolated cancer cells are considerably more often detected in the group of T3/T4 tumours when compared to  the  T1/T2  group  (72%  vs  57%,  p < 0.001) (28). Correspondingly, M ESCOLI et al . in their study observed a  significant  correlation  between  detection  of  isolated cancer cells and infiltration of the intestinal wall (pT) and TNM tumour stage (14). We have analysed the T feature in the study groups of several selected authors (5, 7, 8, 11, 13, 23). Despite the differences in the T1-T4 tumours ratio,  and  the  differences  obtained  in  the  procedure results, none of the publications shows statistical analysis of the problem. In our study we found the correlation between  the  obtained  results  and  depth  of  intestinal infiltration according to TNM classification - the results of sensitivity were significantly worse for T3 tumours in comparison with T2 tumours. However, as has already been mentioned, due to considerable differences in group sizes, the subject requires further research.

statistically significant relationship between dye amount, tumour  size  and  detection  rate  was  observed  in  some single reports (23, 24). Table 5 summarises data from several  publications  where  tumour  size  in  centimetres together with related parameters, achieved in SNB, and amount and type of used dye were determined. The ROC curve analysis of our material did not show a statistically significant relationship between the obtained results and maximum tumour size, tumour surface area and percentage of involvement of circular lumen of the intestine.

In conclusion, no clinical features of neoplastic disease were found, assessed macroscopically and intraoperatively, which could have affected the qualification of patients for the procedure of LM in colorectal cancer. It was found that the accuracy of the method is statistically significantly  decreased  by  the  factors  assessed  in the  histopathological examination : macrometastases in lymph nodes, infiltration of perinodal tissue and vessel infiltration. The noteworthy problem of the qualification of patients for SNB remains open from the point of view of clinical features, and requires further analysis of greater groups of patients.

## Acknowledgements

The study was supported by a research grant (grant number NN403  3844  33)  awarded  by  the  Polish  Committee  for Scientific  Research  (KBN) of the Polish Ministry of Science and Higher Education.

## References

- 1. I NTERNATIONAL A GENCY FOR R ESEARCH ON C ANCER ,  W ORLD H EALTH O RGANIZATION :  GLOBOCAN 2008 . Cancer Incidence, Mortality and Prevalence Worldwide in 2008. http://globocan.iarc.fr/
- 3. W RIGHT F. C., L AW C. H., B ERRY S., S MITH A. J. Clinically important aspects of lymph node assessment in colon cancer . J Surg Oncol , 2009, 99 : 248-525.
- 2. F IGUEREDO A., C OOMBES M. E., M UKHERJEE S. A djuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev , 2008, 3 : CD005390.
- 4. I DDINGS D., B ILCHIK A. The biologic significance of micro metastatic disease and sentinel lymph node technology on colo rectal cancer. J Surg Oncol , 2007, 96 : 671-677.
- 6. D ES G UETZ G., U ZZAN B., N ICOLAS P. et al . Is sentinel lymph node mapping in colorectal cancer a future prognostic factor ? A metaanalysis. World J Surg , 2007, 31 : 1304-1312.
- 5. B ILCHIK A. J., N ORA D. T., S OBIN L. H. et al. Effect of lymphatic mapping  on  the  new  tumor-node-metastasis  classification  for colorectal cancer. J Clin Oncol , 2003, 21 : 668-672.
- 7. L IM S.  J.,  F EIG B.  W.,  W ANG H. et  al . Sentinel  lymph  node evaluation does not improve staging accuracy in colon cancer . Ann Surg Oncol , 2008, 15 : 46-51.
- 9. VAN DER Z AAG E.  S.,  B USKENS C.  J.,  K OOIJ N. et al . Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping : a comparative study. Eur J Surg Oncol , 2009, 3 : 10651070.
- 8. S AHA S., S EGHAL R., P ATEL M. et al . A multicenter trial of sentinel lymph node mapping in colorectal cancer : Prognostic implications for nodal staging and recurrence. Am J Surg , 2006, 191 : 305-310.
- 10. B RODERICK -V ILLA G.,  K O A.,  O'C ONNELL T.  X.,  G UENTHER J.  M., D ANIAL T., D I F RONZO L. A . Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer ? Cancer J , 2002, 8 : 445-450.

- 11. B ILCHIK A. J., D I N OME M., S AHA S. et al . Prospective multicenter trial of staging adequacy in colon cancer : preliminary results. Arch Surg , 2006, 141 : 527-533, discussion 533-534.
- 13. Q UADROS C.  A.,  L OPES A.,  A RAUJO I.,  F REGNANI J.  H.,  F AHEL F . Upstaging benefits and accuracy of sentinel lymph node mapping in colorectal adenocarcinoma nodal staging. J Surg Oncol , 2008, 98 : 324-330.
- 12. B ILCHIK A.  J.,  T ROCHA S.  D. : Lymphatic mapping and sentinel node  analysis  to  optimize  laparoscopic  resection  and  staging  of colorectal cancer : an update . Cancer Control , 2003 , 10 : 219-223.
- 14. M ESCOLI C.,  R UGGE M.,  P UCCIARELLI S. et al . High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer . J Clin Pathol , 2006, 59 : 870-874.
- 16. V IEHL C.  T.,  G ULLER U.,  C ECINI R. et al . Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer : results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer . Ann Surg Oncol , 2013, 19 : 1959-1965.
- 15. M URAWA D.,  N OWACZYK P.,  H ÜNERBEIN M. et  al .  One  hundred consecutive cases of sentinel lymph node mapping in colon cancerthe  results  of  prospective,  single-centre  feasibility  study  with implementation of immunohistochemical staining. Int J Colorectal Dis , 2011, 26 : 897-902.
- 17. VAN DER P AS M.  H.,  M EIJER S.,  H OEKSTRA O.  S. et al . Sentinellymph-node procedure in colon and rectal cancer : a systematic review and meta-analysis . Lancet Oncol , 2011, 12 : 540-550.
- 19. B ONJER H. J., H OP W. C., N ELSON H. et al . Laparoscopically assisted vs open colectomy for colon cancer : A meta-analysis. Arch Surg , 2007, 142 : 298-303.
- 18. K OYANAGI K.,  B ILCHIK A.  J.,  S AHA S. et al . Prognostic  relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial . Clin Cancer Res , 2008, 14 : 7391-7396.
- 20. C AHILL R. A., B EMBENEK A., S IROP S. et al . S entinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer. Ann Surg Oncol , 2009, 16 : 2170-2180.
- 21. C AHILL R. A.,  L EROY J,  M ARESCAUX J . Could lymphatic mapping and sentinel node biopsy provide oncological providence for local resectional techniques for colon cancer ? A review of the literature. BMC Surg , 2008, 8 : 17.
- 22. N owaczyk P.,  M urawa D.,  P ołoM k. et al . Analysis of sentinel lymph  node  biopsy  results  in  colon  cancer  in  regard  of  the anthropometric features of the population and body composition assessment formulas . Langenbecks Arch Surg , 2012, 397 : 779786.
- 24. V IEHL C.  T.,  H AMEL C.  T.,  M ARTI W.  R. et al .  Identification  of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surg , 2003, 27 : 12851290.
- 23.  V IEHL C.  T.,  G ULLER U.,  L ANGER I. et al . Factors  influencing  the success of in vivo sentinel lymph node procedure in colon cancer patients : Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. World J Surg , 2013, 37 : 873-877.
- 25. T HOMAS K. A., L ECHNER J., S HEN P., W ATERS G. S., G EISINGER K. R., L EVINE E. A . Use of sentinel node mapping for cancer of the colon : 'to map or not to map'. Am Surg , 2006, 72 : 606-611.
- 27. B EMBENEK A., R OSENBERG R., W AGLER E. et al . Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg , 2007, 245 : 858-863.
- 26. T IFFET O., K ACZMAREK D., C HAMBONNIRE M. L. et al . Combining radioisotopic and blue-dye technique does not improve the falsenegative rate in sentinel lymph node mapping for colorectal cancer. Dis Colon Rectum , 2007, 50 : 962-970.
- 28. W ASIF N., F ARIES M. B., S AHA S. et al . Predictors of occult nodal metastasis in colon cancer : results from a prospective multicenter trial. Surgery , 2010, 147 : 352-357.
- 29. W OOD T.  F.,  S PIRT M.,  R ANGEL D. et  al . Lymphatic  mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc , 2001, 15 : 715-719.

P. Nowaczyk, M.D., Ph.D.

Wielkopolska Cancer Centre, ul. Garbary Street 15,

61-866 Poznań, Poland

Tel.

:  +48 61-8850-600

Tel./fax  :  +48 61-8850-601

Mobile  :  +48 607-807-947

E-mail  :  piotr\_nowaczyk@o2.pl